From: Effect of age on response to anti-VEGF agents in patients with center involving diabetic macular edema in a tertiary hospital
Age
< 60
> 60
Post–pre-BCVA*
Post–pre-CST*
Post–pre-BCVA
Post–pre-CST
Mean
Injection type
Ranibizumab
19.13
− 228.13
4.18
− 100.29
Aflibercept
4.26
− 117.21
5.70
− 91.40